MIRA INFORM REPORT

 

 

Report Date :

30.04.2014

 

IDENTIFICATION DETAILS

 

Name :

NESTOR PHARMACEUTICALS LIMITED

 

 

Registered Office :

House No. D-38, Sujan Singh Park,  Opposite  Khan Market, New Delhi – 110003

 

 

Country :

India

 

 

Financials (as on) :

31.03.2013

 

 

Date of Incorporation :

13.10.1975

 

 

Com. Reg. No.:

55-007959

 

 

Capital Investment / Paid-up Capital :

Rs.278.084 Millions

 

 

CIN No.:

[Company Identification No.]

U24231DL1975PLC007959

 

 

IEC No.:

0590025767

 

 

TIN No.:

07720021125

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

DELN05870E

 

 

PAN No.:

[Permanent Account No.]

AAACN1547Q

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer, Exporter and Trader of Drugs Capsule, Injection, Tablet, Ointment, Syrup and Powder.   

 

 

No. of Employees :

900 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (27)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 1900000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track record.

 

There are losses recorded by the company during 2013.

 

However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES:

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2014

 

Country Name

Previous Rating

(31.12.2013)

Current Rating

(31.03.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

US investment bank Goldman Sachs has upgraded its outlook on Indian markets as it expects positive impact of the election cycle.

 

India’s economy may grow 4.7 % in the current financial year, lower than the official estimate of 4.9 %, Fitch Rating said. The global rating agency expects the economy to pick up in the next two financial years.

 

Global ratings agency Standard & Poor said increasing focus by India Inc on lowering debt is likely to improve their credit profiles.

 

Singapore (1.1 million Indian tourists in 2012), Thailand (one million), the United Arab Emirates ().98 million) and Malaysia ().82 million) emerged as the preferred holidays hotspots for Indians. The total figure is expected to increase to 1.93 million by 2017, according to the latest Eurmonitor international report.

 

There is a $29.34 bn outward foreign direct investment by domestic companies between April and January of 2013/14 which has seen some signs of recovery according to a Care Ratings report.

 

There are 264 number of new companies being set up every day on average during 2014. Most of them are registered in Mumbai. India had 1.38 million registered companies at the end of January, 2014.

 

Twitter like messaging service Weibo Corporation has filed to raise $ 500 million via a US initial public offering. Alibaba, which owns a stake in Weibo is expected to raise about $ 15 billion New York this year in the highest profile Internet IPO since Facebook’s in 2012.

 

Bharti Airtel has raised Rs.2453.2 crore (350 million Swiss Francs) by selling six-year bonds at a coupon rate of three per cent and maturing in 2020. This is the largest ever bond offering by an Indian company in Swiss Francs. Bharat Petroleum Corporation raised 175 million Swiss Francs by selling five year bonds at 2.98 % coupon rate in February.

 

Indian Oil Corporation plans to invest Rs 7650 crore in setting up a petrochemical complex at its almost complete Paradip refinery in Odhisha in three to four years. The company board is set to consider the setting up of a 700000 tonne per annum polypropylene plant at an estimated cost at Rs.3150 crore.

 

Global chief information officers at gathering in Bangalore in April to meet Indian startups at an event called Tech50 Watchout for Little Eye Labs-Facebook type deals in the making.

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

ICRA

Rating

Fund Based Facilities = B+

Rating Explanation

Have high risk of default

Date

January 2013

 

 

Rating Agency Name

ICRA

Rating

Non Fund Based Facilities = A4

Rating Explanation

Have minimal degree of safety and carry very high credit risk

Date

January 2013

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Ramesh Pandey

Designation :

Manager

Contact No.:

91-124-4045162

Date :

28.04.2014

 

 

LOCATIONS

 

Registered Office :

House No. D-38, Sujan Singh Park,  Opposite  Khan Market, New Delhi – 110003, India

Tel. No.:

91-124-4045162

Fax No.:

Not Available

E-Mail :

ashokkkher@rediffmail.com

hr@nestorpharmaceuticals.com

nestorexport@nestorpharmaceuticals.com

lifecomesfirst@nestorpharmaceuticals.com

nestor_pharm@sify.com

Website :

http://www.nestorpharma.com

Location :

Owned

 

 

Factory 1 :

11 Western Extension Area, Faridabad – 121001, Haryana, India

Tel. No.:

91-129-2481229 / 30

 

 

Factory 2 :

 

 

L-43, Verna Industrial Estate,  Salcete, Goa – 403722, Maharashtra, India

Tel. No.:

91-832-2783005 / 2783006

E-Mail :

nestorgoa@nestorpharmaceuticals.com

 

 

Factory 3 :

 

 

Plot No. 5 and 6, I.D.A. Phase II, District Medak, Andhra Pradesh, India

Tel. No.:

91-8455-240691

E-Mail :

nestorhyd@nestorpharmaceuticals.com

 

 

Correspondence Address : 

S-22/40, DLF Phase – III, Near Neel Kanth Hospital, Gurgaon – 122002, Haryana, India 

 

 

Branch Offices / Sales Offices / C and F :

Located At:

 

·         Dehradun

·         Faridabad

·         Ghaziabad

·         Kolkata

·         Hyderabad

·         Jaipur

·         Orissa

·         Assam

·         Raipur

·         Indore

·         Patna

 

 

DIRECTORS

 

As on 30.09.2013

 

Name :

Mr. Denis Basil Moraes

Designation :

Whole Time Director

Address :

3 Ocean Residency, Alto Chicalim – 403711, Goa, Maharashtra, India

Date of Birth/Age :

14.06.1957

Date of Appointment :

01.10.1998

DIN No.:

01613237

 

 

Name :

Mr. Rahul Sehgal

Designation :

Director

Address :

B-364, New Friends Colony, Delhi – 110065, India

Date of Birth/Age :

07.03.1956

Date of Appointment :

01.03.2011

PAN No.:

ABLPS5980K

DIN No.:

03105193

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74899DL1995PLC071315

NESTOR BASIC DRUGS LIMITED

Director

31/10/2009

31/10/2009

-

Active

NO

2

U74899DL1995PLC071314

NESTOR FORMULATIONS (INDIA) LIMITED

Director

31/10/2009

31/10/2009

-

Active

NO

3

U74899DL1990PTC041244

B.S. INDUSTRIES PRIVATE LIMITED

Director

18/06/2010

18/06/2010

-

Active

NO

4

U01111DL1997PTC087693

GOLDEN TULIP FARMS PRIVATE LIMITED

Director

18/06/2010

18/06/2010

-

Active

NO

5

U24231DL1975PLC007959

NESTOR PHARMACEUTICALS LIMITED

Director

01/03/2011

01/03/2011

-

Active

NO

 

 

Name :

Mr. Arjundas Bhajandas Khatri

Designation :

Additional Director

Address :

36-B, Gopal Bagh, Indore – 452004, Andhra Pradesh, India

Date of Birth/Age :

05.11.1949

Date of Appointment :

01.03.2011

DIN No.:

03499054

 

 

KEY EXECUTIVES

 

Name :

Mr. Ramesh Pandey

Designation :

Manager

 

 

Name :

Mrs. Sonika Sharma

Designation :

Secretary

Address :

304, 10th Block, Four Storey, East of Kailash, Delhi – 110065, India

Date of Appointment :

01.08.2012

PAN No.:

BBNPS6156E

 

 

MAJOR SHAREHOLDERS

 

As on 30.09.2013

 

Names of Shareholders

 

No. of Shares

Rahul Sehgal

 

10141120

Meenu Sehgal

 

6504000

Mehar Sehgal

 

3059600

Prashant Sehgal

 

3863600

Business Search India Private Limited, India

 

4240000

Amrit Lal Aggarwal

 

40

Shivani Sehgal

 

40

Parakh Sehgal

 

40

Total

 

27808440

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2013

 

Category

Percentage

Bodies corporate

15.25

Directors or relatives of Directors

84.75

Total

100.00

 

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer, Exporter and Trader of Drugs Capsule, Injection, Tablet, Ointment, Syrup and Powder.   

 

 

Products :

Products Descriptions

ITC Code

Medicines 

29411002

 

 

Terms :

 

Selling :

Cash and Credit (30 Days)

 

 

Purchasing :

Cash and Credit (30 Days)

 

 

GENERAL INFORMATION

 

Customers :

Retailers and Others

 

 

No. of Employees :

900 (Approximately)

 

 

Bankers :

·         Andhra Bank, M – 35, Connaught Circus, New Delhi, Delhi - 110001, India

·         Punjab National Bank, Large Corporate Branch, Tolstoy House, Tolstoy Marg, Delhi - 110001, India

 

 

Facilities :

SECURED LOANS

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

 

 

Rupee term loans from banks

5.027

12.250

Loans taken for vehicles

2.940

4.795

Short Term Borrowings

 

 

Rupee term loans from banks

618.647

545.082

Total

626.614

562.127

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Deepak Bhargava and Company

Chartered Accountants

Address :

109 Anupam Apartments, M B Road, Opposite Saket, New Delhi -110068, India

PAN No.:

AAAPB4263E

 

 

Subsidiary Company :

·         Nostrum Limited

 

 

Sister Concerns : 

·         Nestor Basic Drugs Limited

CIN No.: U74899DL1995PLC071315

·         Nestor Formulations (India) Limited

CIN No.: U74899DL1995PLC071314

·         B.S. Industries Private Limited

CIN No.: U74899DL1990PTC041244

·         Golden Tulip Farms Private Limited

CIN No.: U01111DL1997PTC087693

 

 


 

CAPITAL STRUCTURE

 

As on 30.09.2013

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

35000000

Equity Shares

Rs.10/- each

Rs.350.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

27808440

Equity Shares

Rs.10/- each

Rs.278.084 Millions

 

 

 

 


FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.03.2013

31.03.2012

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

278.084

278.084

(b) Reserves & Surplus

 

200.578

276.640

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

478.662

554.724

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

37.817

29.045

(b) Deferred tax liabilities (Net)

 

20.248

20.586

(c) Other long term liabilities

 

0.000

0.000

(d) long-term provisions

 

6.570

6.048

Total Non-current Liabilities (3)

 

64.635

55.679

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

618.647

545.082

(b) Trade payables

 

75.680

86.104

(c) Other current liabilities

 

58.964

52.213

(d) Short-term provisions

 

0.000

0.209

Total Current Liabilities (4)

 

753.291

683.608

 

 

 

 

TOTAL

 

1,296.588

1,294.011

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

158.372

168.642

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

0.000

0.000

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

284.638

277.323

(c) Deferred tax assets (net)

 

0.000

0.000

(d)  Long-term Loan and Advances

 

0.000

0.000

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

443.010

445.965

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

391.021

387.943

(c) Trade receivables

 

399.624

381.721

(d) Cash and cash equivalents

 

12.981

8.283

(e) Short-term loans and advances

 

49.952

70.099

(f) Other current assets

 

0.000

0.000

Total Current Assets

 

853.578

848.046

 

 

 

 

TOTAL

 

1,296.588

1,294.011

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

 

1,008.121

1,623.834

 

 

Other Income

 

0.948

1.435

 

 

TOTAL                                         (A)

 

1,009.069

1,625.269

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

 

829.538

1,337.197

 

 

Purchase of Stock-in-trade

 

0.000

0.000

 

 

Changes in Inventories of finished goods, work-in-progress and stock-in-trade

 

(2.591)

7.151

 

 

Employee Benefits Expenses

 

87.439

98.543

 

 

Other Expenses

 

74.592

87.115

 

 

TOTAL                                         (B)

 

988.978

1,530.006

 

 

 

 

 

Less

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

 

20.091

95.263

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

 

83.832

87.561

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

 

(63.741)

7.702

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

 

12.422

12.390

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                   (G)     

 

(76.163)

(4.688)

 

 

 

 

 

Less

TAX                                                                  (H)

 

(0.100)

0.561

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

 

(76.063)

(5.249)

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

 

38.609

43.858

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

 

(37.454)

38.609

 

 

 

 

 

 

Earnings/ (Loss) Per Share (Rs.)

 

(2.74)

(0.19)

 

 

KEY RATIOS

 

PARTICULARS

 

 

 

31.03.2013

31.03.2012

PAT / Total Income

(%)

 

(7.54)

(0.32)

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

 

(7.55)

(0.29)

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

 

(7.53)

(0.46)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

 

(0.16)

(0.01)

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

 

1.37

1.03

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

 

1.13

1.24

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

 

31.03.2012

31.03.2013

 

 

Rs. In Millions

Rs. In Millions

Share Capital

 

278.084

278.084

Reserves & Surplus

 

276.640

200.578

Net worth

 

554.724

478.662

 

 

 

 

long-term borrowings

 

29.045

37.817

Short term borrowings

 

545.082

618.647

Total borrowings

 

574.127

656.464

Debt/Equity ratio

 

1.035

1.371

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

 

31.03.2012

31.03.2013

 

 

Rs. In Millions

Rs. In Millions

Sales

 

1,623.834

1,008.121

 

 

 

(37.917)

 

 

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

 

31.03.2012

31.03.2013

 

 

Rs. In Millions

Rs. In Millions

Sales

 

1,623.834

1,008.121

Profit

 

(5.249)

(76.063)

 

 

(0.32%)

(7.55%)

 

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last two years

Yes

12]

Profitability for last two years

Yes

13]

Reasons for variation <> 20%

-----------

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

No

21]

Market information

----------

22]

Litigations that the firm / promoter involved in

----------

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

----------

26]

Buyer visit details

----------

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

Yes

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

UNSECURED LOANS:

 

Particulars

31.03.2013

Rs. In Millions

31.03.2012

Rs. In Millions

Long Term Borrowings

 

 

Intercorporate deposits

2.000

2.000

Loans and advances from related parties

27.850

10.000

Total

29.850

12.000

 

 

FINANCIAL RESULTS:

 

During the year ended 31st March, 2013 the company has earned Profit/(loss) after tax of Rs.(76.063) Millions and no Dividend has been recommended.

 

 

 

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10441196

11/07/2013

20,000,000.00

Andhra Bank

M – 35, Connaught Circus, New Delhi, Delhi - 110001, India

B81263485

2

10254197

08/01/2011 *

287,500,000.00

PUNJAB NATIONAL BANK

Bo : Large Corporate Branch, Tolstoy House, Tolstoy Marg, New Delhi, Delhi - 110001, India

B07156193

3

10226410

10/06/2010

2,540,000.00

Andhra Bank

M – 35, Connaught Circus, New Delhi, Delhi - 110001, India

A88426002

4

10222589

27/04/2010

1,770,000.00

Andhra Bank

M – 35, Connaught Circus, New Delhi, Delhi - 110001, India

A86633740

5

10222590

27/04/2010

1,770,000.00

Andhra Bank

M – 35, Connaught Circus, New Delhi, Delhi - 110001, India

A86634102

6

10140759

29/12/2012 *

432,500,000.00

Andhra Bank

M – 35, Connaught Circus, New Delhi, Delhi - 110001, India

B66055740

7

80023852

09/03/2007 *

325,000,000.00

Andhra Bank

M – 35, Connaught Circus, New Delhi, Delhi - 110001, India

-

8

90064114

03/02/2000

35,000,000.00

Andhra Bank

M – 35, Connaught Circus, New Delhi, Delhi - 110001, India

-

*Date of modification Charges

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Computer

·         Vehicles

·         Furniture and Fixture

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.52

UK Pound

1

Rs.101.77

Euro

1

Rs.83.92

 

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

VNT


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

2

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.